47 results
Page 2 of 3
424B3
pxdue4 lkr9dr1
17 Sep 21
Prospectus supplement
8:37am
8-K
EX-10.1
o4ztqg9l9lcs
15 Sep 21
Departure of Directors or Certain Officers
4:49pm
424B3
223x1r3hxokf i6nogrg
12 Aug 21
Prospectus supplement
4:21pm
8-K
EX-3.2
9hudt8
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
425
mnmua0hrh8pk8be1
7 Jul 21
Business combination disclosure
4:11pm
S-4
EX-10.18
ohfxxec2mq26x134n
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.20
ef9o6q vwy8
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.17
2wqhm
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.15
lgphj 4vx
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.21
r8hapd6eks0h45bsz
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.19
kudxqfmdq 7k5
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.16
qdl7r50drp 4p62z
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-2.1
e7l87x1
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
f6ccm4ph40mf1 tdp
8 Jan 21
Business combination disclosure
7:02am
8-K
EX-4.1
7is0avak31v
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-10.1
rl4r8jtbxo0
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-10.1
ea2 k1d4t4u
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm